Suchergebnisse - %22Clinical Study%22

PubPharm (2.405)

1

Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Tolaney, S. | Goel, S. | Nadal, J. | +7

2

Exposure to a Mixture of Endocrine-Disrupting Chemicals and Metabolic Outcomes in Belgian Adolescents

enthalten in: Environmental science & technology | 2023

von Cai, A. | Remy, S. | Lenters, V. | +5

3

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

enthalten in: Nature communications | 2023

von Newsome, P. | Sanyal, A. | Neff, G. | +8

4

Targeted literature review exploring the predictive value of estimated glomerular filtration rate and left ventricular mass index as indicators of clinical events in Fabry disease

enthalten in: Orphanet journal of rare diseases | 2023

von Haycroft, B. | Stevenson, A. | Stork, R. | +4

5

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria : an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Ogutu, B. | Yeka, A. | Kusemererwa, S. | +28

CommentIn: Lancet Infect Dis. 2023 Sep;23(9):990-992. - PMID 37327810

6

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd) : 2-year results from a randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Lafayette, R. | Kristensen, J. | Stone, A. | +10

CommentIn: Lancet. 2023 Sep 9;402(10405):827-829. - PMID 37591290

7

Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections : a retrospective posthoc analysis in Kisumu County, western Kenya

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Chemwor, G. | Andagalu, B. | Onyango, I. | +16

8

Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors

enthalten in: Journal of thrombosis and haemostasis : JTH | 2023

von Liu, W. | Xue, F. | Fu, R. | +15

CommentIn: J Thromb Haemost. 2023 Jun;21(6):1429-1431. - PMID 37179074

9

HLX22, an anti-HER-2 monoclonal antibody, in patients with advanced solid tumors overexpressing human epidermal growth factor receptor 2 : an open-label, dose-escalation, phase 1 trial

enthalten in: Investigational new drugs | 2023

von Zhu, X. | Ding, Y. | Wang, Q. | +3

10

PRECYCLE : multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant

enthalten in: Trials | 2023

von Degenhardt, T. | Fasching, P. | Lüftner, D. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[241]